| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Advantage Solutions (ADV) | Goldman Sachs/ Morgan Stanley | $100.00 | n.a. | |||
| ShotSpotter (SSTI) | Roth Capital Partners/ Northland Capital Markets | $34.50 | n.a. | |||
| Venator Materials PLC (VNTR) | BofA Merrill Lynch | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| Liberty Oilfield Services (BDFC) | Morgan Stanley/ Goldman, Sachs/ Wells Fargo Securities/ Citigroup/ J.P. Morgan/ Evercore ISI | 20.00 | $12.00 | $13.00 | $250.00 | 1-Star |
| Withdrawn | ||||||
| BioLight Life Sciences Ltd. (BOLT) (u) | Feltl and Company/ Rodman & Renshaw a unit of H.C. Wainwright & Co.) | 2.14 | $5.60 | $5.60 | $12.00 | N/C |
| IRONSHORE (TBA) | BofA Merrill Lynch/ Citigroup/ J.P. Morgan/ UBS Investment Bank | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| N/C = No Call – Not enough input to make a call | ||||||
| New Terms | ||||||
| Bright Scholar Education Holdings (BEDU) | Morgan Stanley/ Deutsche Bank Securities | 15.00 | $8.00 | $10.00 | $135.00 | S/O |
| Gardner Denver Holdings (GDI) | Goldman, Sachs/ Citigroup/ UBS Investment Bank/ KKR/ Simmons & Company International (Energy Specialists of Piper Jaffray)/ Deutsche Bank Securities/ Baird/ Credit Suisse/ Morgan Stanley | 41.30 | $23.00 | $26.00 | $1,011.85 | S/O |
| Guaranty Bancshares (GNTY) | Sandler O’Neill + Partners/ Stephens | 2.00 | $26.00 | $28.00 | $54.00 | S/O |
| Liberty Oilfield Services (BDFC) | Morgan Stanley/ Goldman, Sachs/ Wells Fargo Securities/ Citigroup/ J.P. Morgan/ Evercore ISI | 20.00 | $12.00 | $13.00 | $250.00 | S/O |
| Modern Media Acquisition (MMDMU) (u) | Macquarie Capital | 15.00 | $10.00 | $10.00 | $150.00 | S/O |
| Plymouth Industrial REIT (PLYM) | D.A. Davidson/ BB&T Capital Markets/ Oppenheimer | $172.50 | S/O | |||
| Solaris Oilfield Infrastructure (SOI) | Credit Suisse/ Goldman, Sachs | 10.60 | $15.00 | $18.00 | $174.90 | S/O |
| Vine Resources (VRI) | Credit Suisse/ Morgan Stanley/ Barclays/ Citigroup/ HSBC | $500.00 | S/O | |||
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of May 1, 2017 | Manager(s) | Offered | Raised | Price | 5/5/17 | Change |
| KKR Real Estate Finance Trust (KREF) | Wells Fargo Securities/ Morgan Stanley/ KKR | 10.25 | $210.13 | $20.50 | $22.13 | 7.95% |
| UroGen Pharma Ltd. (URGN) | Jefferies/ Cowen and Company | 4.47 | $58.15 | $13.00 | $14.00 | 7.69% |
| Biohaven Pharmaceutical Holding (BHVN) | Morgan Stanley/ Piper Jaffray/ Barclays Capital | 8.33 | $141.67 | $17.00 | $17.91 | 5.35% |
| TPG Pace Energy Holdings (TPGEU) (u) | Deutsche Bank Securities/ Goldman, Sachs | 60.00 | $600.00 | $10.00 | $10.14 | 1.40% |
| Antero Resources Midstream Management (AMGP) | Morgan Stanley/ Barclays/ J.P. Morgan | 37.25 | $875.38 | $23.50 | $22.28 | -5.19% |
| Ovid Therapeut (OVID) | Citigroup/ Cowen and Company | 5.00 | $75.00 | $15.00 | $12.25 | -18.33% |
| u (unit offering) | ||||||
